Equities

Yamashita Health Care Holdings Inc

9265:TYO

Yamashita Health Care Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,212.00
  • Today's Change32.00 / 1.47%
  • Shares traded300.00
  • 1 Year change+4.59%
  • Beta0.7685
Data delayed at least 20 minutes, as of Nov 15 2024 04:41 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

YAMASHITA HEALTH CARE HOLDINGS,INC. is a Japan-based company mainly engaged in the sale of medical equipment. The Company operates through three business segments. The Medical Equipment Sales segment is engaged in the provision of general equipment, general medical consumables, endoscopes used in minimally invasive treatments, blood analyzers used in specialized fields, as well as medical equipment maintenance services and medical waste collection and transportation business. Medical Device Manufacture and Sale segment is engaged in the provision of implantable bone materials and other orthopedic implants products. The Medical Mall segment is engaged in the equipment leasing business and facilities management and operation business for medical clinics, dispensing pharmacies, day service facilities, fitness clubs and other health related facilities in Fukuyama, Hiroshima Prefecture. The Company also develops medical communication network business.

  • Revenue in JPY (TTM)62.72bn
  • Net income in JPY501.00m
  • Incorporated2017
  • Employees606.00
  • Location
    Yamashita Health Care Holdings Inc3-6-15, Watanabedori, Chuo-kuFUKUOKA-SHI 812-0027JapanJPN
  • Phone+81 924022922
  • Fax+81 924022962
  • Websitehttps://www.yhchd.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
9265:TYO since
announced
Transaction
value
MicrosonicAnnounced30 May 202430 May 2024Announced-17.86%121.00k
Yugengaisha Kagoshima Ortho MedicalDeal completed27 Nov 202327 Nov 2023Deal completed3.08%--
Data delayed at least 20 minutes, as of Nov 15 2024 04:41 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sincere Co Ltd6.35bn274.77m3.47bn57.0011.771.2817.500.546943.0043.00994.76395.461.213.536.88111,395,300.005.363.988.945.5732.4029.464.442.691.67--0.454337.896.737.34347.1879.5232.1747.58
KAWAMOTO CORPORATION31.26bn461.69m4.72bn436.009.870.620110.280.150979.6679.665,393.351,267.551.579.203.2471,691,000.002.134.034.037.7117.3017.791.362.371.3525.060.44511.19-2.544.66-46.2541.6216.7435.10
Kowa Co Ltd6.39bn726.57m4.80bn213.005.891.535.030.7506162.57162.571,414.88623.861.242.825.8729,992,250.0014.386.0623.339.1045.6846.3711.625.391.1013.550.276222.732.167.1962.08---10.57--
Data Horizon Co Ltd4.91bn-901.84m5.08bn374.00--1.76--1.04-71.15-71.15387.43226.700.699818.213.3813,130,090.00-13.14-8.40-20.33-12.1327.9039.93-18.77-7.731.17-46.560.5284--13.5317.28-21.41--64.50--
KAINOS Laboratories, Inc.5.24bn615.86m5.45bn146.008.170.77927.491.04146.29146.291,244.141,533.730.6323.243.2835,882,720.007.436.929.219.2650.1851.8411.7610.803.11--0.078419.622.711.6012.2810.57-9.8316.36
Aso International Inc3.60bn421.09m5.51bn276.0013.352.0614.551.5384.5284.52721.30546.461.2514.527.6513,039,030.0014.61--16.47--44.72--11.70--7.5939.33----11.12--14.27------
Yamashita Health Care Holdings Inc62.72bn501.00m5.65bn606.0011.180.64857.840.09197.83197.8324,816.183,411.072.6417.765.65103,493,400.002.112.235.746.4513.7412.460.79720.84721.01--0.0033.155.770.0071164.8432.063.8410.76
Leoclan Co Ltd19.80bn136.06m5.75bn176.0042.421.0322.630.290322.9622.963,346.78943.511.56368.493.41--1.222.192.384.8213.2210.820.78041.172.40-------25.64-11.32-49.85-28.60-19.34--
Precision System Science Co., Ltd.3.98bn-1.12bn7.39bn158.00--1.78--1.86-40.59-40.59144.04149.930.49261.585.4625,189,580.00-13.88-3.81-18.40-5.0923.8830.40-28.18-5.531.49-16.260.2488---24.60-1.9015.31---24.26--
Koken Ltd10.22bn565.86m7.90bn287.0013.510.60787.800.7729114.49114.492,066.952,545.070.49912.003.0135,597,010.002.763.703.414.7545.6946.695.547.191.8122.340.306825.88-0.16054.92-15.8414.33-39.876.96
Data as of Nov 15 2024. Currency figures normalised to Yamashita Health Care Holdings Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

1.24%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 03 Oct 202412.30k0.48%
Nikko Asset Management Co., Ltd.as of 04 Oct 20245.90k0.23%
Daiwa Asset Management Co. Ltd.as of 30 Sep 20245.70k0.22%
Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Oct 20242.30k0.09%
BlackRock Japan Co. Ltd.as of 03 Oct 20242.20k0.09%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 19 Feb 20241.40k0.06%
Asset Management One Co., Ltd.as of 03 Oct 2024900.000.04%
Amundi Asset Management SA (Investment Management)as of 02 Oct 2024538.000.02%
State Street Global Advisors (Japan) Co. Ltd.as of 06 Mar 2023200.000.01%
Norinchukin Zenkyoren Asset Management Co., Ltd.as of 03 Oct 2024100.000.00%
More ▼
Data from 30 Nov 2023 - 07 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.